Dr. Reddy's Laboratories Limited
RDY
$12.68
-$0.025-0.20%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.48% | 3.48% | 15.58% | 19.73% | 38.36% |
| Total Depreciation and Amortization | 11.74% | 9.08% | 12.56% | 13.95% | 9.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.72% | -44.36% | -124.59% | -152.79% | -109.59% |
| Change in Net Operating Assets | -205.08% | -719.57% | -189.24% | -130.12% | 51.21% |
| Cash from Operations | -33.83% | -53.36% | -33.72% | -24.24% | 7.09% |
| Capital Expenditure | -80.08% | -67.09% | -50.59% | -40.17% | -4.19% |
| Sale of Property, Plant, and Equipment | -45.06% | 87.93% | 1,602.89% | 1,076.61% | 296.45% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 160.71% | 111.81% | -7.62% | 17.65% | 12.96% |
| Cash from Investing | -24.12% | -19.92% | -15.98% | 3.84% | 10.67% |
| Total Debt Issued | 233.68% | 769.71% | 322.61% | -- | 153.35% |
| Total Debt Repaid | 85.17% | 96.39% | 96.94% | 75.75% | 38.75% |
| Issuance of Common Stock | -78.59% | -81.54% | 79.09% | 118.75% | 541.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.09% | 1.09% | -28.80% | -28.80% | -28.80% |
| Other Financing Activities | 289.00% | 304.72% | -30.38% | -22.29% | -11.54% |
| Cash from Financing | 434.86% | 345.66% | 139.60% | 86.46% | 58.19% |
| Foreign Exchange rate Adjustments | 10.33% | 117.42% | 114.66% | -118.58% | -107.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 308.11% | -151.26% | -320.69% | 114.37% | 107.81% |
